News & Events
Debate over biobank donation compensation – what if your genes lead to a blockbuster drug?
Check out this fascinating article in Fast Company authored by Christina Farr debating ethical issues in how biobank donors should be compensated if their DNA leads to a blockbuster discoveries by big pharma. One of the case studies examined is donors whose rare...
On March 7th, Diana Caldwell serving on CEO panel held at Butler University
Butler University is hosting a CEO Panel discussion moderated by Butler MBA Association President, Barry Dunham, on March 7th including Pearl Pathways’ own CEO and President, Diana Caldwell. Caldwell, with other industry experts, will share career reflections and...
See the video from the Life Sciences Lunch series discussing Clinical Research…
View the outstanding panel discussion on clinical research at the IHIF and Barnes & Thornburg luncheon event featuring Pearl Pathways’ CEO and President, Diana Caldwell here. For information on future IHIF programs with updates from Life Science industry...
Join in Upcoming Life Sciences Lunch Series, February 16th with Diana Caldwell as panelist
The Indiana Health Industry Forum (IHIF) and Barnes & Thornburg present “Clinical Trials from a Study Site Perspective” featuring Pearl Pathways’ own President and CEO, Diana Caldwell as a panelist. This presentation and luncheon will be held on February 16th at...
Follow us on Twitter @PearlPathways
Follow us on Twitter! Pearl IRB is part of a family of companies under the umbrella of Pearl Pathways. We have just launched the @PearlPathways twitter account which will include relevant IRB and clinical research updates about the industry and Pearl IRB. To keep up...